BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8737192)

  • 1. Transdermal estrogen replacement therapy in normal perimenopausal women: effects on pituitary-ovarian function.
    De Leo V; Lanzetta D; D'Antona D; De Palma P
    Gynecol Endocrinol; 1996 Feb; 10(1):49-53. PubMed ID: 8737192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
    Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women.
    De Leo V; Lanzetta D; Morgante G; De Palma P; D'Antona D
    Contraception; 1997 Apr; 55(4):239-43. PubMed ID: 9179456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA; Moghissi KS; Borin K
    Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
    Sherman BM; West JH; Korenman SG
    J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some aspects on pituitary function in human and rat anovulatory cycles.
    Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B
    Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1981 Aug; 24(2):159-72. PubMed ID: 6794980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cycle and hormone changes during perimenopause: the key role of ovarian function.
    Burger HG; Hale GE; Dennerstein L; Robertson DM
    Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
    Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
    van der Mooren MJ; Demacker PN; Thomas CM; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.